GlyR α 2 Antibodies

Santa Cruz Biotechnology offers a broad range of GlyR α 2 monoclonal antibodies for investigating glycine receptor function in the central nervous system. GlyR α 2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA) applications. GlyR α 2 functions as a key component in inhibitory neurotransmission, actively modulating synaptic activity and maintaining neuronal excitability. Understanding GlyR α 2 mechanisms is crucial for motor control and sensory processing research. Abnormal GlyR α 2 activity has been linked to various neurological conditions, highlighting its significance in neuroscience research. Investigating GlyR α 2 expression patterns can reveal important insights into neural development and synaptic plasticity. Studying GlyR α 2 distribution helps researchers better understand neurotransmitter receptor clustering at synaptic sites. Current research focuses on how GlyR α 2 influences neural circuit formation and maintenance throughout development. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of GlyR α 2's role in neurological health and disease progression.